Is Zomedica Going Out Of Business?

Olivia Mangat

Updated on:

Is Zomedica Going Out Of Business
Rate this post

Are you wondering if Is Zomedica Going Out Of Business? You’re in the right place to find out. There is a lot of excitement in the animal health business about Zomedica’s Truforma platform, which will likely change how vets diagnose animals.

For investors, the company’s possible success is interesting, but they are still determining what will happen in the future. Since Zomedica is making little money and its stock price is low, a lot of people are asking if Is Zomedica Going Out Of Business.

This article will explain Zomedica’s current situation in detail. We will look at the problems it has in selling more and making money. By looking at these factors, we want to understand what the company will face in the future and if it can overcome its problems and be successful.

About Zomedica

Let’s explain Zomedica’s story in a simpler way for everyone to understand. Zomedica is a company that helps vets by making new and creative tools to find pet health problems. Their main product, TRUFORMA™, is a device that allows vets to diagnose thyroid or adrenal problems in pets.

However, Zomedica also faced some difficult times, just like any other company. One major concern was that because their stock prices were really low, they might be removed from the stock market. However, Zomedica succeeded even with these difficulties. 

They stayed above water by making good choices and proving that they could recover when things got difficult. Although Zomedica has had some difficulties, they are still working hard to make sure pets receive the care they need.

Is Zomedica Going Out Of Business?

I have good news: Zomedica is not closing, even though you may have heard otherwise. With Robert Cohen as the CEO since January 1, the company is continuing as planned. Cohen has made a big impact, guiding Zomedica through some tough times in the business world.

One major challenge they had was the possibility of being kicked out of the stock exchange because their shares were not worth much. But you know what? Zomedica did it; they kept their share price above the minimum level and stayed on the stock exchange as “ZOM”. They are determined and make smart decisions.

And they’re not just surviving – they’re doing good. Their stock price is rising, which means they are doing well financially. Additionally, they are continuing to make progress with TRUFORMA™, their most important product. This is important for Zomedica, and they are making sure they do it well. So, you don’t have to worry about Zomedica going away.

Zomedica Pharmaceuticals Fundamental Analysis

Macroaxis helps investors look at how well Zomedica Pharmaceuticals Corp is doing financially by looking at their quarterly and yearly statements, indicators, and fundamental ratios. 

We want to help investors figure out how much Zomedica Pharmaceuticals is worth by using all the information that is available to the public. We use numbers and information about the quality of Zomedica Pharmaceuticals Corp to figure out how much it is worth. 

Quantitative analysis is looking closely at financial statements to see how well a company is doing. In contrast, the qualitative analysis looks at non-number things that are important for a company to grow.

Zomedica Sales Performance

Zomedica has been doing well recently. Their newest financial reports have some really good numbers, especially in sales. In the last three months of 2023, they made a huge $7. Three million in sales, which is 19% more than what they made at the same time in 2022. 

The Diagnostics and Therapeutic Devices parts of the business did well, with a big increase of 144% and 16% in sales. But there’s more good news. In 2023, Zomedica made a total of $25. 2 million, which is 33% more than the previous year. 

Their medical treatment devices section expanded by 28%, and the medical testing section increased by a huge 252%. TRUFORMA® products and new items in their product selection were important for this success.

And you know what? The party is still doing well in 2024. In the first three months of the year, they made $6. 3 million, which is 14% more than last year. Both their medical devices and testing divisions are still getting bigger. Is Zomedica going out of business? They’re doing well, and they’ll do even better in the future.

Zomedica Announces First Quarter 2024 Financial Results

Early 2024 was profitable for Zomedica. They made $6.3 million, 14% more than early 2023’s $5.5 million. Diagnostics rose 86% and Therapeutic Devices 9% from the previous year to this year. 

Used items took in $4.0 million, up 7% from last year. It comprised 64% of sales. Money from durable goods rose 30% to $2. The company gained 66% this quarter. Even though $9.6 million was spent, the non-GAAP operational burn was $4. 4 million, as predicted for 2024. 

The company started 2023 well, according to CEO Lisa Heaton. He stated their growth goals gave the corporation its finest start ever. He liked that they added more things and worked harder to sell them. He noted that clinical evidence supports PulseVet and TRUFORMA. Mr. Smith anticipates the future. Heaton thinks Zomedica might make $100 million or more. He believes they have an excellent growth strategy and market position.

Financial Health Of Zomedica

Zomedica is doing well financially. Their stock, called “ZOM” on the NYSE American Exchange, ended at $0. One thousand seven hundred sixty on May 24, 2024, and went up a little in after-hours trading. They are worth about $172. 471 million, which means they are doing well in the market.

Zomedica is also doing well when it comes to earning money. They made $6. Three million in sales in the first three months of 2024. That is a good increase of 14% from before, and they are making a big 66% profit.

Their money situation is really good. They have a lot of money, $91 million, and they don’t have any debt to pay. They have $260. Nine million for their shareholders, and they don’t owe any money compared to what they own, which is a good sign.

When they look at their financial statement, they have $275. One million in things they own and only owe $14. 2 These numbers show that the company is doing well financially. They have a reliable income, no debt, and enough money to keep things going well and buy new things.

However, it is wise to be careful. It’s smart to talk to experts about your money because things can change. They can look at everything and give you good advice.

Is Zomedica a Good Stock to Buy?

Want to know if ZOM is a good stock to buy? Your investment goals, how much danger you’re willing to take, and how long you plan to hold on to the money will all affect whether or not it’s a good investment.

Investment Goals: If you’re seeking a stock with the potential for high long-term returns, ZOM might fit the bill. The company is working on innovative products in a rapidly growing market. However, keep in mind that ZOM is still in the early growth stages, and its products have yet to be widely adopted. This means there’s a risk that it may fail over the long term.

Risk Tolerance: Analysts say that investing in ZOM is risky. As it continues to grow, it will have to deal with competition from both new and old veterinary businesses. ZOM might be worth looking into if you are okay with taking on more risk in exchange for the chance of increasing your benefits.

Ultimately, your specific goals, finances, and level of risk will determine if ZOM is a good buy. Research something carefully or talk to a financial adviser before you decide to invest.

Conclusion: Is Zomedica Going Out Of Business 

In conclusion, although people were worried about Zomedica’s money at first, the company has proven to be strong and has grown. With the release of Truforma and good leadership, they have overcome problems like low prices for their stock. 

Recent reports show that their sales are growing and their finances are strong. Zomedica has done well by making new products and improving sales. This puts them in a good position for the future in the competitive animal health market. 

Although investing in Zomedica has some risks, its recent success shows a hopeful future and removes worries about what’s to come.

FAQsIs Zomedica Going Out Of Business

Should Zomedica Keep Going?

Our prediction for Zomedica Pharmaceuticals stock says that it is a good time to buy right now. This is because, in the next year, Zomedica Pharmaceuticals stock prices are likely to rise by 113.72%.

Will Zomedica Be Taken Off The List?

They will still be traded on the NYSE American under the code “ZOM” for Zomedica’s common shares.

Do I Want To Hold Zomedica Stock?

Zomedica Pharmaceuticals Corp is a “Cautious Hold” for us because you are willing to take on more risk than most people do, and the financial horizon is 90 days.

Did Zomedica Split In Two?

The reverse split of 80-1 also brings the number of shares to the same level as its peers, which could make it more appealing to stock investors. Because of this, institutional investment could go up if the reverse split leads to a higher share price and fewer outstanding shares.

The Reason Zomedica is Stocking Up Is Still Being Determined.

Zomedica (ZOM) stock is going up today because the company and Qorvo Biotechnologies agreed to a planned restructuring.

You may also read!

Is Maskc Going Out Of Business?

Is Maskc Going Out Of Business?

Is American Car Center Going Out Of Business?

Leave a Comment